Literature DB >> 16902278

Cognitive deficits in familial Alzheimer's disease associated with M239V mutation of presenilin 2.

Anna Rita Giovagnoli1, Gabriella Marcon, Giorgio Giaccone, Anna Maria Confaloni, Fabrizio Tagliavini.   

Abstract

The neuropsychological assessment of non-demented subjects with gene mutation of familial Alzheimer's disease (AD) provides a model for exploring the early cognitive features of the disease. We evaluated 1 patient and 6 non-demented subjects belonging to a family with AD with M239V mutation of the presenilin 2 gene, aiming to verify the contribution of specific cognitive patterns to the characterization of familial AD. One patient, 3 non-demented subjects with M239V mutation and 3 subjects without mutation from the same family underwent neuropsychological testing. The patient's cognitive profile was characterized by anosognosia, visuospatial agnosia, apraxia and fluent aphasia. Of the 3 non-demented subjects with mutation, 1 showed no deficits, another constructive apraxia and the third spatial perception and memory deficits. The 3 subjects without mutation showed normal abilities. The cognitive deficits of the non-demented subjects with mutations indicate focal dysfunction of the posterior cortical areas, resembling the more extended parieto-occipito-temporal dysfunction of the demented patient. Such grading of visuospatial, praxis, and language impairments highlights a distinctive pattern related to the M239V mutation of the presenilin 2 gene. Copyright (c) 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902278     DOI: 10.1159/000094972

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  4 in total

1.  PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.

Authors:  Liling Dong; Caiyan Liu; Longze Sha; Chenhui Mao; Jie Li; Xinying Huang; Jie Wang; Shanshan Chu; Bin Peng; Liying Cui; Qi Xu; Jing Gao
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  Translational Research in Alzheimer's and Prion Diseases.

Authors:  Giuseppe Di Fede; Giorgio Giaccone; Mario Salmona; Fabrizio Tagliavini
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.

Authors:  Yuno Song; Hong-Duck Kim; Min-Kwon Lee; Il-Hwa Hong; Chung-Kil Won; Hyoung-Woo Bai; Seung Sik Lee; SungBeom Lee; Byung Yeoup Chung; Jae-Hyeon Cho
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

4.  Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.

Authors:  Ayako Suzuki; Nobuto Shibata; Koji Kasanuki; Tomoyuki Nagata; Shunichiro Shinagawa; Nobuyuki Kobayashi; Tohru Ohnuma; Yoshihide Takeshita; Eri Kawai; Toshiki Takayama; Kenya Nishioka; Yumiko Motoi; Nobutaka Hattori; Kazuhiko Nakayama; Hisashi Yamada; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.